[go: up one dir, main page]

CN102190650A - Method for preparing indoquinoline tartrate - Google Patents

Method for preparing indoquinoline tartrate Download PDF

Info

Publication number
CN102190650A
CN102190650A CN2011100774028A CN201110077402A CN102190650A CN 102190650 A CN102190650 A CN 102190650A CN 2011100774028 A CN2011100774028 A CN 2011100774028A CN 201110077402 A CN201110077402 A CN 201110077402A CN 102190650 A CN102190650 A CN 102190650A
Authority
CN
China
Prior art keywords
preparing
preparation
tartrate
iii
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011100774028A
Other languages
Chinese (zh)
Inventor
王德传
徐云根
甘宗捷
张迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN2011100774028A priority Critical patent/CN102190650A/en
Publication of CN102190650A publication Critical patent/CN102190650A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及药物合成领域。具体涉及用于镇痛的κ-阿片受体激动剂茚喹诺啉酒石酸盐的制备方法,其特征是:1-(四氢吡咯-1-甲基)-四氢异喹啉与6-氯-2,3-二氢-茚-3-酮-1-羧酸,以氯化亚砜为缩合剂、三乙胺为缚酸剂,DMAP为催化剂条件下反应制得。本发明还公开了制备茚喹诺啉酒石酸盐所用到的中间体的制备方法。本发明制备方法原料易得、后处理方便、收率高,同时避免了剧毒试剂氰化钾的使用,更符合绿色化学的要求。The invention relates to the field of drug synthesis. Be specifically related to the preparation method of the κ-opioid receptor agonist indene quinoline tartrate for analgesia, it is characterized in that: 1-(tetrahydropyrrole-1-methyl)-tetrahydroisoquinoline and 6-chloro -2,3-Dihydro-indene-3-one-1-carboxylic acid, prepared under the conditions of using thionyl chloride as the condensation agent, triethylamine as the acid-binding agent, and DMAP as the catalyst. The invention also discloses a preparation method of an intermediate used in the preparation of indenequinoline tartrate. The preparation method of the invention has easy-to-obtain raw materials, convenient post-treatment, high yield, avoids the use of highly toxic reagent potassium cyanide, and is more in line with the requirements of green chemistry.

Description

The preparation method of indenes quinolizidine morpholine tartrate
Technical field
The present invention relates to the synthetic field of medicine.Be specifically related to be used for the new preparation process of analgesic κ-opioid receptor agonist indenes quinolizidine morpholine tartrate.The used intermediates preparation of preparation indenes quinolizidine morpholine tartrate is also disclosed.
Background technology
The chemistry of indenes quinolizidine morpholine tartrate is called 1-(Pyrrolidine-1-methyl)-2-(6-chloro-2,3-dihydro-indenes-3-ketone-1-carbonyl)-1,2,3,4-tetrahydroisoquinoline tartrate is a kind of high reactivity of contriver's early-stage Study invention and the κ-opioid receptor agonist of highly selective.Show through radioligand-binding study, this compound has very high affinity and selectivity to κ-opiate receptor, in the mouse analgesic test, demonstrate stronger analgesic activities (CN1887872A and WO2008009215), more further investigate at present.The structural formula (I) of indenes quinolizidine morpholine tartrate is as follows:
Figure BSA00000461957400011
The free alkali of the disclosed I of patent CN1887872A (the indenes quinolizidine morpholine, preparation method II) comprises:
Figure BSA00000461957400012
Wherein DCC is a dicyclohexylcarbodiimide, and DMAP is the 4-Dimethylamino pyridine, and EDCI is 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide hydrochloride, and HOBT is an I-hydroxybenzotriazole.
Wherein the preparation method of intermediate compound IV is as follows:
Figure BSA00000461957400021
Patent CN1887872A is disclosed to exist following shortcoming by compound III and IV through the method for condensation prepared II, low as the condensation productive rate, the condensing agent costliness, and the by product of generation is difficult for removing, and increases post-processing difficulty.The synthetic route of key intermediate IV is long, and uses poisonous reagent potassium cyanide, and labour protection requires high, and is big to environmental hazard.Therefore, be necessary to seek the efficient height, toxicity is low, the synthetic method that environmental pollution is little.
Summary of the invention
The objective of the invention is to seek that a kind of reaction raw materials is easy to get, convenient post-treatment, yield are higher, constant product quality, eco-friendly indenes quinolizidine morpholine preparation method.
The preparation of target compound (I), the present invention adopts following method:
1-(Pyrrolidine-1-methyl)-tetrahydroisoquinoline (III) and 6-chloro-2,3-dihydro-indenes-3-ketone-1-carboxylic acid (IV) is that condensing agent, triethylamine are acid binding agent with the sulfur oxychloride, DMAP makes II under the catalyzer condition.Preferably under-15 ℃ to 45 ℃ temperature condition, reacted 45 minutes to 4 hours.Also preferably will react products obtained therefrom again through column chromatography purification.Reaction solvent is the mixed solvent of a kind of in toluene, methylene dichloride or acetonitrile or two kinds preferably.More preferably toluene.
The Compound I I that makes again with the tartrate salify, promptly get target compound indenes quinolizidine morpholine tartrate (I).This step reaction solvent is the mixed solvent of a kind of in acetone, isopropyl ether, glycol dimethyl ether, tetrahydrofuran (THF), ethyl acetate or methylene dichloride or two kinds preferably.More preferably acetone.
The reaction formula of above-mentioned preparation process is as follows:
Figure BSA00000461957400022
When preparing II by compound III and IV, the molar ratio of III and IV and sulfur oxychloride preferred 1: 0.8~1.2: 1.1~2.5.Preferred 1: 1: 1.5.
When preparing II by compound III and IV, preferred-25 ℃~55 ℃ of temperature of reaction.More preferably-10 ℃~0 ℃.
When preparing II by compound III and IV, the investing method of IV adds in batches or is suspended in the solvent with solid and is added dropwise to.Preferably be suspended in the solvent and be added dropwise to.
When preparing with above-mentioned preparation method of the present invention, wherein the yield of intermediate II is than the yield high about 20% of patent WO2008009215A1 report.
The invention also discloses the preparation method of midbody compound IV, comprise that with 3-chloroaniline (VIII) be raw material, earlier through diazotization, again with the maleic anhydride condensation, promptly get 3-chlorobenzene Succinic Acid (VII), make acyl chlorides through sulfur oxychloride or phosphorus trichloride reaction, cyclization obtains intermediate (IV) under aluminum chloride catalysis again.
Reaction formula is as follows:
Figure BSA00000461957400031
Wherein chlorizating agent is sulfur oxychloride or phosphorus trichloride; Solvent orange 2 A is methylene dichloride, chloroform or oil of mirbane.
When preparing IX by VIII, VIII: Sodium Nitrite: the molar ratio of fluoroboric acid preferred 1: 1~1.2: 1.1~2.5.More preferably preferred 1: 1: 2.
When preparing IX by compound VIII, preferred-25 ℃~25 ℃ of the temperature of dropping Sodium Nitrite.More preferably 0 ℃~5 ℃.
When preparing VII, preferably make catalyzer with titanous chloride or aluminum chloride by IX.
The preferred sulfur oxychloride of chlorizating agent wherein.Solvent orange 2 A is methylene dichloride more preferably.
When preparing IV by compound VI I, the mol ratio of VII and chlorizating agent, aluminum chloride preferred 1: 1.2~5: 1.2~3.More preferably 1: 3.5: 2.
The preparation method of above-mentioned intermediate compound IV compares with the method for WO2008009215A1, and this synthetic route has that reaction raw materials is easy to get, convenient post-treatment, yield be than advantages such as height, has avoided the use of poisonous reagent potassium cyanide simultaneously, more meets the requirement of Green Chemistry.
Embodiment
Embodiment 1
Synthesizing of 3-chlorine diazobenzene fluoroborate (IX)
With the 3-chloroaniline (63.8g, 0.5mol) and 41.2% fluoborate solution (220ml 1.0mol) mixes, stir also cryosel bath cooling down, (34.5g 0.5mol) is dissolved in the cold soln that 70ml water is made into to splash into Sodium Nitrite, dripped off 0~5 ℃ of controlled temperature in about 1 hour.0.5 after hour, filter, the solid diazonium salt is with 95% washing with alcohol twice, again with ether washing three times.Naturally dry, get product 3-chlorine diazobenzene fluoroborate 107g, yield 95%.m.p.142-143 ℃
Embodiment 2
Synthesizing of 3-chloro-phenyl-Succinic Acid (VII)
Adding 15% Titanium Trichloride Solution in the 1L three-necked bottle (350ml, 13mol), ice bath is cooled to 0 ℃, stir down, drip by maleic anhydride (19.6g, 0.2mol) and sodium hydroxide (16g, 0.4mol) be dissolved in the mixing solutions that 125ml water is made into, keep 0~5 ℃ of temperature, finished, and added acetone 500ml again in about 0.5 hour, stir down, add IX (45g 0.2mol), added in about 1 hour in batches.Rose to stirring at room 3 hours, and steamed and remove acetone, debris is put the refrigerator cold-storage crystallization, and filter next day, and frozen water is washed, and crude product water recrystallization gets product 3-chloro-phenyl-Succinic Acid 28.38g.Yield 62.2%.m.p.174-175℃.
Embodiment 3
6-chloro-2,3-dihydro-indenes-3-ketone-1-carboxylic acid (IV) synthetic
With VII (22.8g, 0.1mol) and sulfur oxychloride (25ml 0.35mol) mixes, and refluxes 2 hours, is cooled to room temperature, to wherein adding the 60ml anhydrous methylene chloride, must reaction solution A.
In addition with aluminum chloride (26.7g, 0.2mol) and anhydrous methylene chloride (100ml) mix, the ice bath cooling is also stirred down, drips above-mentioned reaction solution A, drips off in about 2 hours, is heated to backflow 3 hours.Reaction solution is poured in 10% hydrochloric acid (375ml), stirred after 0.5 hour suction filtration.The gained solid is with about 550ml acetic acid ethyl dissolution, and extract saturated sodium carbonate solution 100ml * 3, combining water layer, with ether 40ml washing, water layer is transferred pH=2 with hydrochloric acid, the solid filtering of generation is used the frozen water washed twice, dry product 13.38g, yield 63.58%.m.p.144~146℃.
Embodiment 4
1-(Pyrrolidine-1-methyl)-2-(6-chloro-2,3-dihydro-indenes-3-ketone-1-carbonyl)-1,2,3,4-tetrahydroisoquinoline (II) synthetic
In the 1L three-necked bottle; add III (10.8g; 50mmol), and triethylamine (11.8g, 150mmol); catalytic amount DMAP and dry toluene (200ml); under the nitrogen protection, be cooled to-10 ℃, drip IV (10.5g then with the cryosel bath; 50mmol) suspension made from dry toluene (100ml) dripped off in about 1 hour.Temperature control is below 0 ℃, and (8.9g 750mmol) and the solution that is made into of dry toluene (100ml), dripped dripping thionyl chloride in about 1 hour.Continue to stir 2 hours.Filter, the gained solid carries out column chromatography for separation (eluent: sherwood oil: ethyl acetate: triethylamine=4: 1: 0.1), get product 12.5g, yield 61.2%.m.p.120~122℃.
Embodiment 5
1-(Pyrrolidine-1-methyl)-2-(6-chloro-2,3-dihydro-indenes-3-ketone-1-carbonyl)-1,2,3,4-tetrahydroisoquinoline tartrate (I) synthetic
In the 500ml three-necked bottle, add II (5g, 12.3mmol) and acetone (100ml), after the stirring and dissolving, 0 ℃ of temperature control, drip tartrate (1.84g, 12.3mmol) and the solution of acetone (100ml) composition.Drip and finish, stir 0.5h, cooling crystallization.Filter, obtain white powdery crystallization 6g, yield 88.2%.m.p.167.7-169.6℃?MS(ESI(+)70V,m/z):408.99([M+H] +,base?peak).
1H-NMR (500MHz, CD 3OD+CF 3COOD), δ (ppm): 7.93 (1H, d), 7.61~7.63 (1H, dd), 7.42~7.44 (1H, t), 7.18~7.26 (4H, m), 6.00~6.03 (1H, m), 4.90~4.93 (1H, m), 4.42 (2H, s), 3.87~4.29 (2H, m), 3.35~3.89 (2H, m), 3.40~3.61 (4H, m) and 2.51~3.11 (2H, m), 2.89~3.00 (2H, m), 2.06~2.10 (4H, m).

Claims (8)

1.一种制备茚喹诺啉酒石酸盐(I)的方法,包括下列制备过程:1. a method for preparing indenequinoline tartrate (I), comprising the following preparation process:
Figure FSA00000461957300011
Figure FSA00000461957300011
2.权利要求1的方法,由III和IV制备II时,III∶IV∶氯化亚砜的投料摩尔比是1∶0.8~1.2∶1.1~2.5。2. the method for claim 1, when preparing II by III and IV, III: IV: the molar ratio of thionyl chloride is 1: 0.8~1.2: 1.1~2.5. 3.权利要求1的方法,由III和IV制备II时,反应溶剂选自甲苯、二氯甲烷或乙腈中的一种或者两种的混合溶剂。3. The method of claim 1, when preparing II by III and IV, the reaction solvent is selected from one or two mixed solvents in toluene, methylene dichloride or acetonitrile. 4.权利要求1的方法,由III和IV制备II时,反应温度是-10℃~0℃。4. The method of claim 1, when preparing II from III and IV, the reaction temperature is -10°C to 0°C. 5.权利要求1的方法,由II和酒石酸制备I时,反应溶剂选自丙酮、异丙醚、乙二醇二甲醚、四氢呋喃、乙酸乙酯或二氯甲烷中的一种或者两种的混合溶剂。5. the method for claim 1, when preparing I by II and tartaric acid, reaction solvent is selected from one or both in acetone, isopropyl ether, ethylene glycol dimethyl ether, tetrahydrofuran (THF), ethyl acetate or methylene dichloride Mixed solvents. 6.权利要求1的化合物(IV)的方法,包括下列制备过程:6. The method for the compound (IV) of claim 1, comprising the following preparation process: 其中氯化剂是氯化亚砜或三氯化磷;溶剂A是二氯甲烷、氯仿或硝基苯。Wherein the chlorinating agent is thionyl chloride or phosphorus trichloride; solvent A is dichloromethane, chloroform or nitrobenzene. 7.权利要求6的方法,由VIII制备IX时,VIII∶亚硝酸钠∶氟硼酸的投料摩尔比是1∶1~1.2∶1.1~2.5。7. The method of claim 6, when preparing IX from VIII, VIII: sodium nitrite: the molar ratio of fluoboric acid is 1: 1~1.2: 1.1~2.5. 8.权利要求6的方法,由IX制备VII时,用三氯化钛或三氯化铝作催化剂。8. The method of claim 6, when preparing VII from IX, use titanium trichloride or aluminum trichloride as a catalyst.
CN2011100774028A 2011-03-30 2011-03-30 Method for preparing indoquinoline tartrate Pending CN102190650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100774028A CN102190650A (en) 2011-03-30 2011-03-30 Method for preparing indoquinoline tartrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100774028A CN102190650A (en) 2011-03-30 2011-03-30 Method for preparing indoquinoline tartrate

Publications (1)

Publication Number Publication Date
CN102190650A true CN102190650A (en) 2011-09-21

Family

ID=44599609

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100774028A Pending CN102190650A (en) 2011-03-30 2011-03-30 Method for preparing indoquinoline tartrate

Country Status (1)

Country Link
CN (1) CN102190650A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554021A (en) * 2013-11-25 2014-02-05 中国药科大学 Indanone tetrahydroisoquinoline derivative as well as preparation method and medical application thereof
CN109369523A (en) * 2018-11-21 2019-02-22 安阳师范学院 A kind of preparation method and use of tetrahydroisoquinoline derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1887872A (en) * 2006-07-12 2007-01-03 中国药科大学 Tetrahydro isoquinoline derivative and its prepn process and medicine use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1887872A (en) * 2006-07-12 2007-01-03 中国药科大学 Tetrahydro isoquinoline derivative and its prepn process and medicine use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554021A (en) * 2013-11-25 2014-02-05 中国药科大学 Indanone tetrahydroisoquinoline derivative as well as preparation method and medical application thereof
CN109369523A (en) * 2018-11-21 2019-02-22 安阳师范学院 A kind of preparation method and use of tetrahydroisoquinoline derivatives

Similar Documents

Publication Publication Date Title
EP1991523B1 (en) Selective androgen receptor modulators
CN102812020B (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
CN101993407B (en) Indoline compound for preparing silodosin and preparation method thereof
KR20090045360A (en) 4-substituted phenoxyphenylacetic acid derivatives
KR20160120282A (en) Method for producing inhibitor of activated blood coagulation factor x (fxa)
TW200813046A (en) Process for the preparation of tiotropium bromide
CN110498770B (en) A kind of method for preparing elagolime intermediate
CN101993406A (en) Indoline compound with optical activity and preparation method thereof
WO2011147102A1 (en) Synthetic method for 6,7-substituents-4-aniline quinazoline
CN103910671B (en) The preparation method of Vismodegib and its intermediate
CN112851646A (en) Preparation method of Tegolrazan
TW200305559A (en) Process for trans-4-amino-1-cyclohexane carboxylic acid derivatives
CN102190650A (en) Method for preparing indoquinoline tartrate
CN108484577A (en) A kind of pyrimidine-quinolones heterocomplex and its preparation method and application
KR20220156560A (en) Synthesis of capsaicin derivatives
WO2015018289A1 (en) Novel method for synthesizing key intermediate of apixaban
CN101037430B (en) (-)-meptazinol double-ligand derivative and/or its salt and preparation method and usage
CN102887856B (en) Method for synthesizing Blonanserin
CN104672180B (en) Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate
CN103804221B (en) A kind of Preparation Method And Their Intermediate of 4-(4-aminophenyl)-3-morpholone
CN100545148C (en) A kind of synthetic method of anti-BPH (benign prostatic hyperplasia) medicament Tamsulosin
CN103396346A (en) Method for producing optically active aminoalcohol derivative
CN1085655C (en) High-optical-purity dinaphthdiol monomenthyl carbonate and its preparing process
CN113214205B (en) A kind of preparation method of chromone derivative
TWI845992B (en) A method for preparing a hepatitis B virus nucleocapsid inhibitor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110921